Maintenance olaparib in patients (pts) with platinum-sensitive relapsed ovarian cancer (PSROC) by somatic (s) or germline (g) BRCA and other homologous recombination repair (HRR) gene mutation status: Overall survival (OS) results from the ORZORA study.
JOURNAL OF CLINICAL ONCOLOGY（2022）
关键词
ovarian cancer,maintenance olaparib,gene mutation status,other homologous recombination repair,platinum-sensitive
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要